Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126904971 | 12690497 | 1 | I | 20160819 | 20160826 | 20160826 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069980 | BRISTOL MYERS SQUIBB | 0.00 | M | Y | 64.00000 | KG | 20160826 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126904971 | 12690497 | 1 | PS | VIDEX | DIDANOSINE | 1 | Unknown | 400 MG, QD | U | 21183 | 400 | MG | GASTRO-RESISTANT CAPSULE, HARD | QD | |||||
| 126904971 | 12690497 | 2 | SS | EPIVIR | LAMIVUDINE | 1 | Oral | 150 MG, UNK | U | 0 | 150 | MG | FILM-COATED TABLET | QD | |||||
| 126904971 | 12690497 | 3 | C | ISENTRESS | RALTEGRAVIR POTASSIUM | 1 | Unknown | U | 0 | FILM-COATED TABLET | |||||||||
| 126904971 | 12690497 | 4 | C | WELLVONE | ATOVAQUONE | 1 | Unknown | UNK UNK, QD | U | 0 | QD | ||||||||
| 126904971 | 12690497 | 5 | C | PROPRANOLOL | PROPRANOLOLPROPRANOLOL HYDROCHLORIDE | 1 | Unknown | 40 MG, QD | U | 0 | 40 | MG | QD | ||||||
| 126904971 | 12690497 | 6 | C | INEXIUM /01479302/ | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | GASTRO-RESISTANT TABLET | QD | |||||
| 126904971 | 12690497 | 7 | C | DUPHALAC | LACTULOSE | 1 | Oral | 1 DF, UNK | U | 0 | 1 | DF | |||||||
| 126904971 | 12690497 | 8 | C | UVEDOSE | CHOLECALCIFEROL | 1 | Oral | 100 IU, UNK | U | 0 | 100 | IU | ORAL SOLUTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126904971 | 12690497 | 1 | HIV infection |
| 126904971 | 12690497 | 2 | HIV infection |
| 126904971 | 12690497 | 3 | HIV infection |
| 126904971 | 12690497 | 4 | Product used for unknown indication |
| 126904971 | 12690497 | 5 | Product used for unknown indication |
| 126904971 | 12690497 | 6 | Product used for unknown indication |
| 126904971 | 12690497 | 7 | Product used for unknown indication |
| 126904971 | 12690497 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126904971 | 12690497 | HO |
| 126904971 | 12690497 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126904971 | 12690497 | Asthenia | |
| 126904971 | 12690497 | Decreased appetite | |
| 126904971 | 12690497 | Hyperkalaemia | |
| 126904971 | 12690497 | Lactic acidosis | |
| 126904971 | 12690497 | Muscle spasms | |
| 126904971 | 12690497 | Nausea | |
| 126904971 | 12690497 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |